Navigation Links
BR Ventures Invests in Semprae Laboratories
Date:3/10/2010

es. The deal represents BRV's first co-investment with Quaker BioVentures, a leading life sciences venture fund headquartered in Philadelphia.

"BR Ventures' investment is yet another endorsement of the great strides we are making to bring Zestra into the homes of women around the world," said Mary Wallace Jaensch, CEO of Semprae Laboratories. "We are igniting the conversation among women and, with the help of our investors, we are expanding our reach and impact."

Semprae Laboratories is a unique investment for BRV, which typically invests in seed stage companies. The deal is the second of the year for the Fund, following an investment in biotechnology company, Adenios, in January.

"We are thrilled to join Quaker BioVentures in this round," said Uma Kakde, Manager of BR Ventures. "This is a one of a kind deal for us. Semprae is addressing an enormous market – over 30 million women in the United States - with a very real need. With proven management and demonstrated execution, we are confident that Zestra will become the standard in this category."


'/>"/>
SOURCE BR Ventures
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Hank Plain Joins Morgenthaler Ventures as Partner
2. Dan Broderick Joins Prolog Ventures as Partner
3. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
4. Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence
5. Khosla Ventures and BIOeCON Form KiOR Inc.
6. Jerusalem Global Ventures Announces $200 Million Growth Equity Fund
7. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
8. Clarus Ventures Closes $660 Million Fund
9. The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C.
10. Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
11. SPO Medical Retains American Capital Ventures for Investor Relations Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... LOUIS , Dec. 23, 2014 ... today that the waiting period under the Hart-Scott-Rodino ... the acquisition expired on December 22, 2014, thereby ... review requirement for the acquisition of the Company ... U.S. antitrust clearance satisfies another condition to closing ...
(Date:12/22/2014)... Brussels (PRWEB) December 22, 2014 The ... the global leader of technical training across the life ... Clinical Data Management (SCDM) to provide the organization's ... certification programs —providing access to the more than 350 ... SCDM members with 10% off when registering for a ...
(Date:12/22/2014)... , Dec. 22, 2014  Alternative Energy ... that it has signed a letter of intent ... has developed and patented a nanotechnology-based development platform ... products that enable rapid on-site collection and testing ... and health issues in an immediate, non-invasive and ...
(Date:12/22/2014)... The American Journal of ... research, reviews and editorials addressing developments and pathways ... published a provocative article exploring the role of ... potential treatment of prostate cancer. , The ... the possibility that there could be a connection ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3ALNE Announces Intention To Acquire BioTechPharma 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4
... DIEGO, Feb. 26 Bio-Matrix Scientific Group, Inc. ... today that the San Diego-based biotechnology company is ... Pick" on WallStreetCorner.com ( http://wallstreetcorner.com/stockpick.html ), an editorial ... and Special Situation profiles are regularly read by ...
... for Biomedical,Research today presented its strategies for drug ... A large computational,project with basic research support and ... under the broad-based Epistemic Drug,Discovery(R) project. , ... Institute, Dr. J.R. Prous, explained that "We,are committed ...
... February 26 ScreenCancer AS, a Norwegian,company ... insurance,companies and individuals, today announced that it ... screening test to its European Cancer,Screening Program. ... a subsidiary of Quest Diagnostics Incorporated (NYSE: ...
Cached Biology Technology:Bio-Matrix Scientific Group Featured as 'Stock Pick' in Oakley's Column on WallStreetCorner.com 2Prous Institute Presents Innovative Approach to Drug Discovery 2ScreenCancer Adds InSure(R) FIT(TM) Colorectal Cancer Screening Test to European Cancer Screening Program 2ScreenCancer Adds InSure(R) FIT(TM) Colorectal Cancer Screening Test to European Cancer Screening Program 3
(Date:12/17/2014)... NEW YORK , Dec. 15, 2014 /PRNewswire-USNewswire/ ... a Good Clinical Practices (GCP) audit to confirm ... Administration (FDA) regulations. This accomplishment enables HITLAB to ... trials utilizing the highest principles for patient safety ... to improve global healthcare access, quality, and delivery ...
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... to their offering. One major ... technology. With continuous advances in technology, it is ... standard that meets the needs and expectations of ...
(Date:12/10/2014)... RALEIGH, N.C. , Dec. 9, 2014  Valencell, ... announced it is seeing a staggering demand from its ... demand, the Company revealed, is not solely coming from ... industries as well. "A wearable is only ... a result, accuracy is the ultimate driver in long-term ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... Sainsbury Laboratory and the John Innes Centre will publish the first ... of disease. They will release the data via a ... system, called GitHub, was also used to crowdsource expertise during the ... around the world will be able to access the RNA sequence ...
... of Illinois at Urbana-Champaign has received a fiveyear, $5.7 million ... corn. These strains have the potential to combat the losses ... A team at the Institute for Genomic Biology in the ... the research. "Ozone can cause major damage and ...
... Since Edison,s first bulb, heat has been a mostly undesirable ... light into heat at the point of need, on the ... The method created by the Rice labs of Michael Wong, ... American Chemical Society journal ACS Nano makes use ...
Cached Biology News:Crowdsourcing to kickstart comeback from ash dieback 2University of Illinois receives grant to study ozone resistance in corn 2Rice uses light to remotely trigger biochemical reactions 2Rice uses light to remotely trigger biochemical reactions 3Rice uses light to remotely trigger biochemical reactions 4
MAGP-2 (C-19)...
Laminin gamma-2 (G-16)...
... Proliferation Kit, For 100 slides. Immunocytochemistry.Sample ... in vitro tissue labeling.Recommended cell number: ... (labeling 1-2 hours).Store at 2-8 C ... Category: Drug Screening & Cellular Assays, ...
Dysadherin 2 (L-15)...
Biology Products: